Ισραήλ - Εβραϊκά - Ministry of Health

cts chemical industries ltd - ferrous gluconate 300 mg - film coated tablets - ferrous gluconate - prevention and treatment of iron deficiency anemias.

Ισραήλ - Εβραϊκά - Ministry of Health

uni-pharma kleon tsetis pharmaceutical laboratories ltd. - ferric hydroxide polymaltose complex as - טיפות - ferric hydroxide polymaltose complex as 50 mg/ml - ferric hydroxide - ferric hydroxide - prevention and treatment of iron deficiency anaemia.

Ισραήλ - Εβραϊκά - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - טבליה - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.

Ισραήλ - Εβραϊκά - Ministry of Health

cts chemical industries ltd, israel - folic acid - טבליה - folic acid 5 mg - folic acid - folic acid - prevention and treatment of folic acid deficiency.

Ισραήλ - Εβραϊκά - Ministry of Health

cts chemical industries ltd - isosorbide-5-mononitrate - קפסולות בשחרור איטי - isosorbide-5-mononitrate 60 mg - isosorbide mononitrate - isosorbide mononitrate - prevention and treatment of angina pectoris.

Ισραήλ - Εβραϊκά - Ministry of Health

cts chemical industries ltd, israel - isosorbide-5-mononitrate - קפסולות בשחרור איטי - isosorbide-5-mononitrate 40 mg - isosorbide mononitrate - isosorbide mononitrate - prevention and treatment of angina pectoris.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis pharma services ag - methylergometrine maleate 125 mcg - tablets - methylergometrine - prevention or treatment of uterine haemorrhage.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.2 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.